Portola Pharmaceuticals, Inc. Selling, General and Administrative Expense
Portola Pharmaceuticals, Inc. reported Selling, General and Administrative Expense of $54.42 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2020-03-31 was $54.42M, a 2.61% increase year-over-year.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2019-12-31 was $59.98M, a 47.67% increase year-over-year.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2019-09-30 was $52.05M, a 34.18% increase year-over-year.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2019-06-30 was $53.85M, a 33.92% increase year-over-year.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2019 was $218.92M, a 44.82% increase from fiscal 2018.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2018 was $151.16M, a 65.92% increase from fiscal 2017.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2017 was $91.11M, a 56.45% increase from fiscal 2016.
- Portola Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2016 was $58.23M, a 49.82% increase from fiscal 2015.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2020-03-31 | $54.42M 10-Q · filed 2020-05-11 | $114.40M derived: sum of 2 quarters · filed 2020-05-11 | $166.45M derived: sum of 3 quarters · filed 2020-05-11 | $220.30M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $59.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $112.03M derived: sum of 2 quarters · filed 2020-02-28 | $165.88M derived: sum of 3 quarters · filed 2020-02-28 | $218.92M 10-K · filed 2020-02-28 |
| 2019-09-30 | $52.05M 10-Q · filed 2019-11-05 | $105.91M derived: sum of 2 quarters · filed 2019-11-05 | $158.94M 10-Q · filed 2019-11-05 | $199.56M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $53.85M 10-Q · filed 2019-08-07 | $106.89M 10-Q · filed 2019-08-07 | $147.51M derived: sum of 3 quarters · filed 2020-05-11 | $186.30M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | $53.03M 10-Q · filed 2020-05-11 | $93.65M derived: sum of 2 quarters · filed 2020-05-11 | $132.44M derived: sum of 3 quarters · filed 2020-05-11 | $172.66M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $40.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $79.41M derived: sum of 2 quarters · filed 2020-02-28 | $119.62M derived: sum of 3 quarters · filed 2020-02-28 | $151.16M 10-K · filed 2020-02-28 |
| 2018-09-30 | $38.79M 10-Q · filed 2019-11-05 | $79.01M derived: sum of 2 quarters · filed 2019-11-05 | $110.55M 10-Q · filed 2019-11-05 | $137.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $40.21M 10-Q · filed 2019-08-07 | $71.75M 10-Q · filed 2019-08-07 | $98.66M derived: sum of 3 quarters · filed 2020-02-28 | $127.51M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $31.54M 10-Q · filed 2019-05-08 | $58.44M derived: sum of 2 quarters · filed 2020-02-28 | $87.30M derived: sum of 3 quarters · filed 2020-02-28 | $107.63M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $26.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $55.76M derived: sum of 2 quarters · filed 2020-02-28 | $76.09M derived: sum of 3 quarters · filed 2020-02-28 | $91.11M 10-K · filed 2020-02-28 |
| 2017-09-30 | $28.86M 10-Q · filed 2018-11-07 | $49.19M derived: sum of 2 quarters · filed 2018-11-07 | $64.21M 10-Q · filed 2018-11-07 | $77.07M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $20.33M 10-Q · filed 2018-08-09 | $35.35M 10-Q · filed 2018-08-09 | $48.21M derived: sum of 3 quarters · filed 2019-03-01 | $61.77M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $15.02M 10-Q · filed 2018-05-10 | $27.88M derived: sum of 2 quarters · filed 2019-03-01 | $41.44M derived: sum of 3 quarters · filed 2019-03-01 | $58.48M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $12.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $26.42M derived: sum of 2 quarters · filed 2019-03-01 | $43.46M derived: sum of 3 quarters · filed 2019-03-01 | $58.23M 10-K · filed 2019-03-01 |
| 2016-09-30 | $13.56M 10-Q · filed 2017-11-09 | $30.60M derived: sum of 2 quarters · filed 2017-11-09 | $45.37M 10-Q · filed 2017-11-09 | $56.23M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $17.04M 10-Q · filed 2017-08-09 | $31.80M 10-Q · filed 2017-08-09 | $42.68M derived: sum of 3 quarters · filed 2018-03-01 | $52.75M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $14.75M 10-Q · filed 2017-05-09 | $25.63M derived: sum of 2 quarters · filed 2018-03-01 | $35.70M derived: sum of 3 quarters · filed 2018-03-01 | $44.62M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $20.95M derived: sum of 2 quarters · filed 2018-03-01 | $29.86M derived: sum of 3 quarters · filed 2018-03-01 | $38.87M 10-K · filed 2018-03-01 |
| 2015-09-30 | $10.07M 10-Q · filed 2016-11-07 | $18.98M derived: sum of 2 quarters · filed 2016-11-07 | $27.99M 10-Q · filed 2016-11-07 | $34.94M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $8.91M 10-Q · filed 2016-08-09 | $17.92M 10-Q · filed 2016-08-09 | $24.87M derived: sum of 3 quarters · filed 2017-03-01 | $31.29M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $9.01M 10-Q · filed 2016-05-06 | $15.96M derived: sum of 2 quarters · filed 2017-03-01 | $22.38M derived: sum of 3 quarters · filed 2017-03-01 | $27.32M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $13.38M derived: sum of 2 quarters · filed 2017-03-01 | $18.31M derived: sum of 3 quarters · filed 2017-03-01 | $23.55M 10-K · filed 2017-03-01 |
| 2014-09-30 | $6.42M 10-Q · filed 2015-11-09 | $11.36M derived: sum of 2 quarters · filed 2015-11-09 | $16.60M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $4.94M 10-Q · filed 2015-08-05 | $10.18M 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | $5.24M 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $15.42M 10-K · filed 2016-02-29 |